Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2009-10-20
Product name
Methoxyamine HCl in Pyridine
supplier name
Thermo Fisher Scientific
Manufacturer Name
Thermo Fisher Scientific
Icons in SDS
Company Information
company name
Thermo Fisher Scientific
Section 2
SECTION 2: Hazards identification
Directive 1999/45/EC: Physical state : Liquid.
Principle Routes of Exposure
Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Inhalation : Toxic by inhalation. Corrosive to the respiratory system. May cause sensitization by inhalation. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion : Harmful if swallowed. May cause burns to mouth, throat and stomach. Skin : Corrosive to the skin. Causes burns. Harmful in contact with skin. May cause sensitization by skin contact. Eyes : Corrosive to eyes. Causes burns. Potential chronic health effects
Potential chronic health
Contains material that can cause target organ damage. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which causes damage to the following organs: kidneys, the nervous system, liver, mucous membranes, peripheral nervous system, gastrointestinal tract, upper respiratory tract, skin, eyes, central nervous system (CNS). Contains material which may cause damage to the following organs: blood, lungs, digestive system. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing wheezing and breathing difficulties asthma Ingestion : Adverse symptoms may include the following: stomach pains Skin : Adverse symptoms may include the following: pain or irritation redness blistering may occur Eyes : Adverse symptoms may include the following: pain watering redness Medical conditions aggravated by over- exposure : Pre-existing respiratory, skin and digestive disorders and disorders involving any other target organs mentioned in this MSDS as being at risk may be aggravated by over- exposure to this product. The preparation is classified as dangerous according to Directive 1999/45/EC and its amendments.
2.1 Classification of the substance or mixture
F; R11 Xn; R20/21/22
Other physicochemical hazards
Highly flammable.
Health hazards
Harmful by inhalation, in contact with skin and if swallowed. See toxicological information (section 11)